Hearing loss from ototoxics

WHO Drug Information

Volumn 11, Issue 1, 1997, Pages 7-10

  Smith, Andrew ^a   Mackenzie, Ian ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; AZITHROMYCIN; BLEOMYCIN; BUMETANIDE; CARBOPLATIN; CHELATING AGENT; CHLORAMPHENICOL; CHLOROQUINE; CISPLATIN; DEFEROXAMINE; ERYTHROMYCIN; ETACRYNIC ACID; FUROSEMIDE; GENTAMICIN; INDOMETACIN; KANAMYCIN; MACROLIDE; NAPROXEN; NEOMYCIN; NETILMICIN; NONSTEROID ANTIINFLAMMATORY AGENT; POLYMYXIN B; QUININE; SALICYLIC ACID DERIVATIVE; STREPTOMYCIN; TOBRAMYCIN; UNINDEXED DRUG;

CONFERENCE PAPER; DRUG MONITORING; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; OTOTOXICITY; PATIENT INFORMATION; VOCATIONAL EDUCATION;

EID: 0030915323     PISSN: 10109609     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Brummett, R.E., Morrison, R.B. The incidence of aminoglycoside antibiotic-induced hearing loss. Archives of Otolaryngology, Head and Neck Surgery, 116: 406-410 1990.
2. Chiodo, A.A., Alberti, P.W. Experimental, clinical and preventive aspects of ototoxicity. European Archives of Otorhinolaryngology, 251: 375-392 (1994).
3. World Health Organization. Severe and complicated Malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84 (suppl 2): (1990).
4. Harpur E. The pharmacology of ototoxic drugs. British Journal of Audiology, 16: 81-93 (1982).
5. Chan L. Status of ototoxic deafness in China. Strategies for prevention of hearing impairment from ototoxic drugs. Unpublished background paper, PBL/WHO, Geneva, 1994.
6. Scrip, Number 2180, 1996. p. 27.
7. National Research Council. Committee on Diet and Health, Food and Nutrition Board, Commission on Life Sciences. Diet and health: implications for reducing chronic disease risk. National Academy Press, Washington, DC, 1989.
8. Verlangieri, A.J., Bush, M.J. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. Journal of American College of Nutrition, 11:131-138 (1992).
9. The Alpha-tocopherol, beta carotene cancer prevention study group: Effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine, 331:141-147 (1994).
10. Hennekens, C.H., Buring, J.E., Manson, J.E. et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. New England Journal of Medicine, 334:1145-1149 (1996).
11. Omenn, G.S., Buring, J.E., Mason, J.E. et al Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine, 334,1150-1155 (1996).
12. Kushi, L.H., Folsom, A.R., Prineas, R.J. et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. New England Journal of Medicine, 334:1156-1162 (1996).
13. Vainio, A., Ollila, J., Matikainen, E. et al. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet, 346: 667 (1995).
14. Vainio, A., Kalso, E., Ollila, J. et al. Kan cancer-patienter som behandlas med morfin köra bil? Tabu, 6: 50 (1996).